Narrative ReviewPrimer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship
Under a Creative Commons license
open access
Keywords
Helicobacter pylori
Antimicrobial Stewardship
Guidance
Therapy
Susceptibility Testing
Test of Cure
Abbreviations used in this paper
CMS
Centers for Medicare and Medicaid Services
FDA
Food and Drug Administration
PPI
proton pump inhibitor
WHO
World Health Organization
Cited by (0)
Conflicts of Interest This author discloses the following: David Y. Graham is a consultant for RedHill Biopharma and Phathom Pharmaceuticals regarding novel Helicobacter pylori therapies. The remaining author discloses no conflicts.
Funding David Y. Graham is supported in part by the Office of Research and Development Medical Research Service Department of Veterans Affairs and Public Health Service Grant No. DK56338, which funds the Texas Medical Center Digestive Diseases Center.
Published by Elsevier Inc. on behalf of the AGA Institute